Altrinsic Global Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-12,700
| Closed | -$1.01M | – | 86 |
|
|
2017
Q2 | $1.01M | Sell |
12,700
-50,000
| -80% | -$3.99M | 0.04% | 77 |
|
|
2017
Q1 | $3.21M | Sell |
62,700
-40,000
| -39% | -$2.05M | 0.11% | 63 |
|
|
2016
Q4 | $3.85M | Buy |
102,700
+30,000
| +41% | +$1.12M | 0.14% | 60 |
|
|
2016
Q3 | $4.93M | Hold |
72,700
| – | – | 0.18% | 57 |
|
|
2016
Q2 | $4.03M | Buy |
72,700
+5,000
| +7% | +$277K | 0.11% | 62 |
|
|
2016
Q1 | $4.25M | Buy |
+67,700
| New | +$4.25M | 0.12% | 65 |
|